Paper9570534
Cholera toxin and cholera toxin B subunit induce IgA switching through the action of TGF-beta 1.
Kim PH and 4 others. J Immunol, 1998. Cited by 56 papers, by iCite.
Cite this record
ConductScience Library. Cholera toxin and cholera toxin B subunit induce IgA switching through the action of TGF-beta 1. Papers, record 9570534. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9570534
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cholera Toxin | Major topic |
| Immunoglobulin A | Major topic |
| Immunoglobulin Class Switching | Major topic |
| Transforming Growth Factor beta | Major topic |
| Animals | |
| B-Lymphocytes | |
| Growth Inhibitors | |
| Immunosuppressive Agents | |
| Lipopolysaccharides | |
| Lymphocyte Activation | |
| Lymphocyte Count | |
| Mice | |
| Mice, Inbred BALB C | |
| Spleen | |
| Stem Cells |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| DK35108 | NIDDK NIH HHS | United States | P01DK035108 | PubMed and NIH |
Source NIH RePORTER
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38140268 | A CTB-SARS-CoV-2-ACE-2 RBD Mucosal Vaccine Protects Against Coronavirus Infection. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/38140268 | PubMed |
| 35632582 | Recombinant BCG to Enhance Its Immunomodulatory Activities. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/35632582 | PubMed |
| 34732259 | Immunomodulatory effects of mesenchymal stem cell-conditioned media on lipopolysaccharide of Vibrio cholerae as a vaccine candidate. | Stem Cell Res Ther | 2021 | https://conductscience.org/library/papers/34732259 | PubMed |
| 32479679 | Nasal vaccination of β7 integrin-deficient mice retains elevated IgA immunity. | Immunol Cell Biol | 2020 | https://conductscience.org/library/papers/32479679 | PubMed |
| 29168738 | Therapeutic Potential of Cholera Toxin B Subunit for the Treatment of Inflammatory Diseases of the Mucosa. | Toxins (Basel) | 2017 | https://conductscience.org/library/papers/29168738 | PubMed |
| 27805617 | Oral administration of a recombinant cholera toxin B subunit promotes mucosal healing in the colon. | Mucosal Immunol | 2017 | https://conductscience.org/library/papers/27805617 | PubMed |
| 26668753 | Cholera toxin B induced activation of murine macrophages exposed to a fixed bacterial immunogen. | Ther Adv Vaccines | 2015 | https://conductscience.org/library/papers/26668753 | PubMed |
| 25563500 | Neutrophils negatively regulate induction of mucosal IgA responses after sublingual immunization. | Mucosal Immunol | 2015 | https://conductscience.org/library/papers/25563500 | PubMed |
| 24982881 | Immunization with the recombinant Cholera toxin B fused to Fimbria 2 protein protects against Bordetella pertussis infection. | Biomed Res Int | 2014 | https://conductscience.org/library/papers/24982881 | PubMed |
| 23147035 | Cholera toxin induces a shift from inactive to active cyclooxygenase 2 in alveolar macrophages activated by Mycobacterium bovis BCG. | Infect Immun | 2013 | https://conductscience.org/library/papers/23147035 | PubMed |
| 22069594 | Toxins-useful biochemical tools for leukocyte research. | Toxins (Basel) | 2010 | https://conductscience.org/library/papers/22069594 | PubMed |
| 21169215 | Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations. | J Gen Virol | 2011 | https://conductscience.org/library/papers/21169215 | PubMed |
| 18650480 | CD19+CD5+ B cells in primary IgA nephropathy. | J Am Soc Nephrol | 2008 | https://conductscience.org/library/papers/18650480 | PubMed |
| 15242946 | Cholera toxin B-subunit gene enhances mucosal immunoglobulin A, Th1-type, and CD8+ cytotoxic responses when coadministered intradermally with a DNA vaccine. | Clin Diagn Lab Immunol | 2004 | https://conductscience.org/library/papers/15242946 | PubMed |
| 12704173 | Immune response induced by recombinant Mycobacterium bovis BCG producing the cholera toxin B subunit. | Infect Immun | 2003 | https://conductscience.org/library/papers/12704173 | PubMed |
| 12100719 | Modulation of human monocytes by Escherichia coli heat-labile enterotoxin B-subunit; altered cytokine production and its functional consequences. | Immunology | 2002 | https://conductscience.org/library/papers/12100719 | PubMed |
| 10582165 | The B-cell system of human mucosae and exocrine glands. | Immunol Rev | 1999 | https://conductscience.org/library/papers/10582165 | PubMed |
| 9927516 | Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression. | J Exp Med | 1999 | https://conductscience.org/library/papers/9927516 | PubMed |
| 9788349 | A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes. | Nat Biotechnol | 1998 | https://conductscience.org/library/papers/9788349 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9570534
GET https://conductscience.org/api/papers/v1/9570534/authors